Jiaqi Cao

Jan 7, 2025 | cell.com | Xu Zha |Xicheng Liu |Mengping Wei |Huanwei Huang |Jiaqi Cao |Shuo Liu | +6 more

Keywords Alzheimer’s disease β-amyloid gut microbiota Bacteroides ovatus lysophosphatidylcholine ferroptosis GPR119 Introduction Alzheimer’s disease (AD) is an incurable neurodegenerative disorder and the predominant form of dementia in elderly individuals, characterized by progressive cognitive impairment and a decline in cognitive function, which gradually prevents patients from performing daily activities.1,2 To date, many hypotheses regarding the pathogenesis of AD have been proposed and...

Mar 26, 2024 | onlinelibrary.wiley.com | Jiaqi Cao |Rong Zhou |Qian He |Ming Zhang

CrAg cryptococcal antigen CT-PNB computed tomography-guided percutaneous needle biopsy EBUS-TBLB endobronchial ultrasound-guided transbronchial lung biopsy PC pulmonary cryptococcosis ROSE rapid on-site evaluation TAT average turnaround time 1 INTRODUCTION Pulmonary cryptococcosis (PC), a subacute or chronic visceral fungal disease, is caused by inhalation of Cryptococcus spores or yeast cells through the respiratory tract.1 It mainly occurs in immunocompromised individuals, such as those...

Mar 19, 2024 | biorxiv.org | Shengjie Hao |Shiyu Wang |Jiaqi Cao |Zhiyuan Xue

AbstractBackground:The development of nanocarriers with precise control over drug release is crucial for targeted therapy.